ArticleAmerican journal of ophthalmology2019

Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept.

Suzann Pershing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.